HighLife
HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.
€80MFinancing round
ParticipantBP
BNP Paribas Développement
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Healthtech · Jul 27, 2026
BNP Paribas Développement is an investment subsidiary whose official portfolio identifies Inbolt. GoCanopy’s company and co-investor coverage also names the subsidiary.
Recorded funding activity
Inbolt uses vision software to guide industrial robots from CAD models under changing factory conditions. Other recorded activity includes HighLife’s transcatheter mitral-valve replacement system and GoCanopy’s data tools for institutional real-estate investors. The subsidiary’s history is distinct from the parent bank and named funds.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $91.7M 1 disclosed · full round size, not this investor’s share